Drug General Information |
Drug ID |
D04DYA
|
Former ID |
DIB016354
|
Drug Name |
SMTP-0
|
Synonyms |
SMTP-0; SMTP compounds (cancer/metabolic disorder/thromboembolism/organ failure); SMTP compounds (cancer/metabolic disorder/thromboembolism/organ failure), TMS; Triprenyl phenols (cancer/metabolic disorder/thromboembolism/organ failure), TMS
|
Indication |
Cancer [ICD9: 140-229; ICD10:C00-C96]
|
Investigative |
[1]
|
Company |
Tokyo University Of Agriculture & Technology Co Ltd
|
Structure |
|
Download
2D MOL
3D MOL
|
Canonical SMILES |
c12c3c(cc(c1C[C@@H]([C@@](O2)(CC/C=C(/CCC=C(C)C)\C)C)O)<br />O)C(=O)NC3
|
Target and Pathway |
Target(s) |
Plasminogen |
Target Info |
Modulator |
[1]
|
KEGG Pathway
|
Neuroactive ligand-receptor interaction
|
Complement and coagulation cascades
|
Staphylococcus aureus infection
|
Influenza A
|
PANTHER Pathway
|
Blood coagulation
|
Plasminogen activating cascade
|
Pathway Interaction Database
|
Angiopoietin receptor Tie2-mediated signaling
|
p75(NTR)-mediated signaling
|
amb2 Integrin signaling
|
Syndecan-4-mediated signaling events
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
PathWhiz Pathway
|
Coagulation
|
Reactome
|
Platelet degranulation
|
Degradation of the extracellular matrix
|
Activation of Matrix Metalloproteinases
|
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
|
Dissolution of Fibrin Clot
|
WikiPathways
|
Complement and Coagulation Cascades
|
Human Complement System
|
Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
|
Activation of Matrix Metalloproteinases
|
Blood Clotting Cascade
|
Dissolution of Fibrin Clot
|
Folate Metabolism
|
Vitamin B12 Metabolism
|
Selenium Micronutrient Network
|
References |
REF 1 | Tranexamic acid in trauma: how should we use it. J Trauma Acute Care Surg. 2013 Jun;74(6):1575-86. |